Description:
We are building the world's first objective mental health diagnostics platform, using mobile-based neurotechnology to measure cognitive activity through the eye. After six years of R&D and multiple clinical iterations, we are now entering trials for our PTSD diagnostic, with additional indications for Anxiety and Depression to follow. As the world faces a growing mental health crisis, we are creating a scalable, objective, and clinically validated approach to diagnosing mental health conditions.
Dec 4, 2025;
from:
dice.com